Repligen | RGEN - 流动资产

金融业

USD

USD 2.95B

现金及等价物

USD 566.02M

USD 94.08M

USD 1.14B

USD 135.83M

USD 542.21M

USD 19.97M

USD 39.54M

1.78K

EPS每股收益

USD 0.48

股本和储备

USD 2.11B

USD 103.83M

债务利息支出

USD 5.5M

USD 7.31M

USD 542.21M

USD 7.12B

USD 13.29M

USD 177.95M

USD 19.97M

普通股股本

USD 56.33M

164.06

USD 19.11M

USD 194M

销售和管理费用

USD 74.36M

USD 170.46M

贸易债权人

USD 30.01M

应收帐款人

USD 158.59M

	流动资产	更改		日
Agilent	USD 4.62B		21M	2025-12
Align Technology	USD 2.66B		38.87M	2026-03
Bio Techne	USD 637.43M		27.92M	2025-12
BioMarin Pharmaceutical	USD 4.61B		651.58M	2026-03
Bristol-Myers Squibb	USD 27.21B		2.18B	2026-03
Bruker	USD 2.21B		138.1M	2025-12
Charles River Laboratories	USD 1.45B		85.06M	2025-12
Danaher	USD 13.94B		1.18B	2026-03
Dentsply International	USD 1.85B		178M	2026-03
General Electric Aerospace	USD 40.36B		235M	2026-03
Henry Schein	USD 4.5B		32M	2026-03
Illumina	USD 2.74B		551M	2026-03
IQVIA Holdings	USD 6.22B		29M	2026-03
Mettler Toledo International	USD 1.36B		81.46M	2025-12
Myriad Genetics	USD 332.6M		12.2M	2025-12
OraSure Technologies	USD 261.91M		21.1M	2025-12
Pacific Biosciences Of California	USD 375.05M		19.18M	2025-12
Pfizer	USD 42.82B		76M	2026-03
Repligen	USD 1.14B		40.9M	2025-12
Revvity	USD 2.24B		95.96M	2025-12
Standard Biotools	USD 454.26M		18.18M	2025-12
Thermo Fisher Scientific	USD 22.32B		6.39B	2026-03
Waters	USD 1.99B		69.86M	2025-12
West Pharmaceutical Services	USD 1.83B		151.4M	2026-03